WW domain interactions regulate the Hippo tumor suppressor pathway

The Hippo kinase pathway is emerging as a conserved signaling pathway that is essential for organ growth and tumorigenesis in Drosophila and mammalians. Although the signaling of the core kinases is relatively well understood, less is known about the upstream inputs, downstream outputs and regulation of the whole cascade. Enrichment of the Hippo pathway components with WW domains and their cognate proline-rich interacting motifs provides a versatile platform for further understanding the mechanisms that regulate organ growth and tumorigenesis. Here, we review recently discovered mechanisms of WW domain-mediated interactions that contribute to the regulation of the Hippo signaling pathway in tumorigenesis. We further discuss new insights and future directions on the emerging role of such regulation.

[1]  Kevin J. Cheung,et al.  Tumor Suppressor LATS1 Is a Negative Regulator of Oncogene YAP* , 2008, Journal of Biological Chemistry.

[2]  Meng Yang,et al.  Color-coded fluorescence imaging of tumor-host interactions , 2006, Nature Protocols.

[3]  K. Hogue,et al.  WW domain-mediated interaction with Wbp2 is important for the oncogenic property of TAZ , 2010, Oncogene.

[4]  Tony Pawson,et al.  WW Domains Provide a Platform for the Assembly of Multiprotein Networks , 2005, Molecular and Cellular Biology.

[5]  K. Guan,et al.  Both TEAD-binding and WW domains are required for the growth stimulation and oncogenic transformation activity of yes-associated protein. , 2009, Cancer research.

[6]  P. Bork,et al.  Characterization of the Mammalian YAP (Yes-associated Protein) Gene and Its Role in Defining a Novel Protein Module, the WW Domain (*) , 1995, The Journal of Biological Chemistry.

[7]  S. K. Zaidi,et al.  Tyrosine phosphorylation controls Runx2‐mediated subnuclear targeting of YAP to repress transcription , 2004, The EMBO journal.

[8]  Jeannie T. Lee,et al.  Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. , 2009, Cancer cell.

[9]  M. Sudol,et al.  Structure and function of the WW domain. , 1996, Progress in biophysics and molecular biology.

[10]  K. Takamune,et al.  A family with Liddle's syndrome caused by a new missense mutation in the beta subunit of the epithelial sodium channel. , 1998, The Journal of clinical endocrinology and metabolism.

[11]  M. Ji,et al.  KIBRA Regulates Hippo Signaling Activity via Interactions with Large Tumor Suppressor Kinases* , 2011, The Journal of Biological Chemistry.

[12]  R. Aqeilan,et al.  Negative regulation of the Hippo pathway by E3 ubiquitin ligase ITCH is sufficient to promote tumorigenicity. , 2011, Cancer research.

[13]  Sho Fujisawa,et al.  Nuclear CDKs Drive Smad Transcriptional Activation and Turnover in BMP and TGF-β Pathways , 2009, Cell.

[14]  Scott A. Peterson,et al.  Characterization of the WW Domain of Human Yes-associated Protein and Its Polyproline-containing Ligands* , 1997, The Journal of Biological Chemistry.

[15]  Jianmin Zhang,et al.  Negative regulation of YAP by LATS1 underscores evolutionary conservation of the Drosophila Hippo pathway. , 2008, Cancer research.

[16]  K. Irvine,et al.  Processing and phosphorylation of the Fat receptor , 2009, Proceedings of the National Academy of Sciences.

[17]  R. Ishima,et al.  Structural features and ligand binding properties of tandem WW domains from YAP and TAZ, nuclear effectors of the Hippo pathway. , 2011, Biochemistry.

[18]  K. Guan,et al.  Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. , 2011, Genes & development.

[19]  Juan Huang,et al.  The apical transmembrane protein Crumbs functions as a tumor suppressor that regulates Hippo signaling by binding to Expanded , 2010, Proceedings of the National Academy of Sciences.

[20]  P. Schmieder,et al.  WW domain sequence activity relationships identified using ligand recognition propensities of 42 WW domains , 2003, Protein science : a publication of the Protein Society.

[21]  Zhengyu Zha,et al.  TAZ Promotes Cell Proliferation and Epithelial-Mesenchymal Transition and Is Inhibited by the Hippo Pathway , 2008, Molecular and Cellular Biology.

[22]  K. Harvey,et al.  Wbp2 cooperates with Yorkie to drive tissue growth downstream of the Salvador–Warts–Hippo pathway , 2011, Cell Death and Differentiation.

[23]  G. Feldmann,et al.  Elucidation of a Universal Size-Control Mechanism in Drosophila and Mammals , 2007, Cell.

[24]  Y. Xiong,et al.  PP1 Cooperates with ASPP2 to Dephosphorylate and Activate TAZ* , 2010, The Journal of Biological Chemistry.

[25]  K. Harvey,et al.  Upstream Regulation of the Hippo Size Control Pathway , 2010, Current Biology.

[26]  J. Wrana,et al.  Phosphorylation of the Tumor Suppressor Fat Is Regulated by Its Ligand Dachsous and the Kinase Discs Overgrown , 2009, Current Biology.

[27]  King Ching Hoa,et al.  Correction for Ho et al., Itch E3 ubiquitin ligase regulates large tumor suppressor 1 tumor-suppressor stability , 2011, Proceedings of the National Academy of Sciences.

[28]  N. Navin,et al.  WW Domain-containing Protein YAP Associates with ErbB-4 and Acts as a Co-transcriptional Activator for the Carboxyl-terminal Fragment of ErbB-4 That Translocates to the Nucleus* , 2003, Journal of Biological Chemistry.

[29]  T. Hunter,et al.  NeW Wrinkles for an Old Domain , 2000, Cell.

[30]  M. Saraste,et al.  Structure of the WW domain of a kinase-associated protein complexed with a proline-rich peptide , 1996, Nature.

[31]  D. Green,et al.  The ubiquitin–protein ligase Itch regulates p73 stability , 2005, The EMBO journal.

[32]  R. M. Simpson,et al.  Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression , 2010, Proceedings of the National Academy of Sciences.

[33]  D. Haber,et al.  salvador Promotes Both Cell Cycle Exit and Apoptosis in Drosophila and Is Mutated in Human Cancer Cell Lines , 2002, Cell.

[34]  M. Sudol,et al.  Mst2 and Lats Kinases Regulate Apoptotic Function of Yes Kinase-associated Protein (YAP)* , 2008, Journal of Biological Chemistry.

[35]  M. MacDonald,et al.  Huntingtin interacts with a family of WW domain proteins. , 1998, Human molecular genetics.

[36]  K. Harvey,et al.  The Salvador–Warts–Hippo pathway — an emerging tumour-suppressor network , 2007, Nature Reviews Cancer.

[37]  K. Vousden,et al.  Cytoplasmic ASPP1 inhibits apoptosis through the control of YAP. , 2010, Genes & development.

[38]  Y. She,et al.  Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability , 2011, Proceedings of the National Academy of Sciences.

[39]  L. Schild,et al.  A de novo missense mutation of the beta subunit of the epithelial sodium channel causes hypertension and Liddle syndrome, identifying a proline-rich segment critical for regulation of channel activity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[40]  R. Aqeilan,et al.  WW domain-containing proteins: retrospectives and the future. , 2012, Frontiers in bioscience.

[41]  Xin Huang,et al.  Structure of a WW domain containing fragment of dystrophin in complex with β-dystroglycan , 2000, Nature Structural Biology.

[42]  Meng Yang,et al.  Whole-body imaging with fluorescent proteins , 2006, Nature Protocols.

[43]  I. Grundke‐Iqbal,et al.  Site‐specific effects of tau phosphorylation on its microtubule assembly activity and self‐aggregation , 2007, The European journal of neuroscience.

[44]  J. Campanelli,et al.  WW and EF hand domains of dystrophin-family proteins mediate dystroglycan binding. , 1999, Molecular cell biology research communications : MCBRC.

[45]  K. Titani,et al.  Hyperphosphorylation of Tau in PHF , 1995, Neurobiology of Aging.

[46]  M. Sudol,et al.  The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[47]  Marius Sudol,et al.  WW and SH3 domains, two different scaffolds to recognize proline‐rich ligands , 2002, FEBS letters.

[48]  Annalisa Pastore,et al.  Y65C Missense Mutation in the WW Domain of the Golabi-Ito-Hall Syndrome Protein PQBP1 Affects Its Binding Activity and Deregulates Pre-mRNA Splicing* , 2010, The Journal of Biological Chemistry.

[49]  Thomas Benjamin,et al.  TAZ, a Transcriptional Modulator of Mesenchymal Stem Cell Differentiation , 2005, Science.

[50]  Peter A. Lawrence,et al.  Four-Jointed Modulates Growth and Planar Polarity by Reducing the Affinity of Dachsous for Fat , 2010, Current Biology.

[51]  M. Sudol Newcomers to the WW Domain-Mediated Network of the Hippo Tumor Suppressor Pathway. , 2010, Genes & cancer.

[52]  G. Halder,et al.  The apical-basal cell polarity determinant Crumbs regulates Hippo signaling in Drosophila , 2010, Proceedings of the National Academy of Sciences.

[53]  Y. Pekarsky,et al.  WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function. , 2005, Cancer research.

[54]  Li Li,et al.  The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. , 2010, Genes & development.

[55]  J. Woodgett,et al.  When pathways collide: collaboration and connivance among signalling proteins in development , 2010, Nature Reviews Molecular Cell Biology.

[56]  W. Deng,et al.  Kibra functions as a tumor suppressor protein that regulates Hippo signaling in conjunction with Merlin and Expanded. , 2010, Developmental cell.

[57]  Li Li,et al.  Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. , 2007, Genes & development.

[58]  P. Bork,et al.  The WW domain: a signalling site in dystrophin? , 1994, Trends in biochemical sciences.

[59]  R. Fehon,et al.  Delineation of a Fat tumor suppressor pathway , 2006, Nature Genetics.

[60]  M. MacDonald,et al.  Huntingtin's WW domain partners in Huntington's disease post-mortem brain fulfill genetic criteria for direct involvement in Huntington's disease pathogenesis. , 2000, Human molecular genetics.

[61]  D. Pan,et al.  The hippo signaling pathway in development and cancer. , 2010, Developmental cell.

[62]  L. Castagnoli,et al.  Physical interaction with Yes-associated protein enhances p73 transcriptional activity. , 2001, The Journal of biological chemistry.

[63]  Ingrid Poernbacher,et al.  The WW domain protein Kibra acts upstream of Hippo in Drosophila. , 2010, Developmental cell.

[64]  Frederic A. Fellouse,et al.  The Hippo pathway regulates Wnt/beta-catenin signaling. , 2010, Developmental cell.

[65]  K. Harvey,et al.  Modularity in the Hippo signaling pathway. , 2010, Trends in biochemical sciences.

[66]  E. Mandelkow,et al.  Tau in Alzheimer's disease. , 1998, Trends in cell biology.

[67]  Franca Fraternali,et al.  Molecular interactions of ASPP1 and ASPP2 with the p53 protein family and the apoptotic promoters PUMA and Bax , 2008, Nucleic acids research.

[68]  I. Hariharan,et al.  The Drosophila Mst Ortholog, hippo, Restricts Growth and Cell Proliferation and Promotes Apoptosis , 2003, Cell.

[69]  Robert M. Hoffman,et al.  The multiple uses of fluorescent proteins to visualize cancer in vivo , 2005, Nature Reviews Cancer.

[70]  Junjie Chen,et al.  Angiomotin-like Proteins Associate with and Negatively Regulate YAP1* , 2010, The Journal of Biological Chemistry.

[71]  A. Pobbati,et al.  Hippo Pathway-independent Restriction of TAZ and YAP by Angiomotin* , 2011, The Journal of Biological Chemistry.

[72]  B. Thompson,et al.  Kibra Is a Regulator of the Salvador/Warts/Hippo Signaling Network , 2010, Developmental cell.

[73]  Sharad Kumar,et al.  The role of individual Nedd4–2 (KIAA0439) WW domains in binding and regulating epithelial sodium channels , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[74]  Meng Yang,et al.  Subcellular imaging in the live mouse , 2006, Nature Protocols.

[75]  Giovanni Cesareni,et al.  Modular protein domains , 2005 .

[76]  R. Aqeilan,et al.  WWOX: Its genomics, partners, and functions , 2009, Journal of cellular biochemistry.

[77]  R. Aqeilan,et al.  WWOX gene and gene product: tumor suppression through specific protein interactions. , 2010, Future oncology.